ConductScience.org, home

Library / Genes

CXCR3: C-X-C motif chemokine receptor 3

1 protein, 207 patents, 0 drugs, 0 trials, 7,710 NIH grants and 14,523 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolCXCR3HGNC
NameC-X-C motif chemokine receptor 3HGNC
NCBI Gene ID2833NCBI Gene
HGNC IDHGNC:4540HGNC
EnsemblENSG00000186810NCBI Gene
AliasesCD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R, Mig-R, MigRNCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P49682C-X-C chemokine receptor type 336815Ensembl, GeneID, HGNCUniProt

Patents 207

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
WO 2026174198 A12026-08-201P49682Espacenet
EP 4754236 A12026-06-102P49682Espacenet
EP 4724076 A22026-04-1575P49682Espacenet
EP 4705273 A22026-03-11240P49682Espacenet
JP 2026035669 A2026-03-04281P49682Espacenet
JP 2026004568 A2026-01-1441096P49682Espacenet
JP 2025538131 A2025-11-2625P49682Espacenet
JP 2025536946 A2025-11-1228P49682Espacenet
JP 2025536947 A2025-11-1243P49682Espacenet
JP 2025147176 A2025-10-0616711P49682Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 7710

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P51OD011132Emory National Primate Research Center462,025NIH's project files
P30CA016672Cancer Center Support Grant442,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award382,025NIH's project files
P30CA008748Cancer Center Support Grant352,025NIH's project files
P30CA068485Cancer Center Support Grant252,025NIH's project files
U19AI082630Durable Alteration of the Human Immune system after Infection or Immunotherapy252,025NIH's project files
P30DK043351Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital222,025NIH's project files
P30CA047904Cancer Center Support Grant212,025NIH's project files
UL1TR001866Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success212,025NIH's project files
P51OD011104Tulane National Primate Research Center202,025NIH's project files

Papers 14523

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42825902PubTator, text miningPubMed
42818140PubTator, text miningPubMed
42816734PubTator, text miningPubMed
42812769PubTator, text miningPubMed
42802565PubTator, text miningPubMed
42802277PubTator, text miningPubMed
42800817PubTator, text miningPubMed
42793346PubTator, text miningPubMed
42770367PubTator, text miningPubMed
42767770PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license